ArticleJournal of imaging2026
Multiscale RGB-Guided Fusion for Hyperspectral Image Super-Resolution.
Article in Journal of imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Hyperspectral imaging (HSI) enables fine spectral analysis but is often limited by low spatial resolution due to sensor constraints. To address this, we propose CGNet, a color-guided hyperspectral super-resolution network that leverages complementary information from low-resolution hyperspectral inputs and high-resolution RGB images. CGNet adopts a dual-encoder design: the RGB encoder extracts hierarchical spatial features, while the HSI encoder progressively upsamples spectral features. A multi-scale fusion decoder then combines both modalities in a coarse-to-fine manner to reconstruct the high-resolution HSI. Training is driven by a hybrid loss that balances L1 and Spectral Angle Mapper (SAM), which ablation studies confirm as the most effective formulation. Experiments on two benchmarks, ARAD1K and StereoMSI, at ×4 and ×6 upscaling factors demonstrate that CGNet consistently outperforms state-of-the-art baselines. CGNet achieves higher PSNR and SSIM, lower SAM, and reduced ΔE00, confirming its ability to recover sharp spatial structures while preserving spectral fidelity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.